# FDA cosmetic recall guidance: what brands should prepare for > FDA's final guidance explains when it can order a cosmetic recall and how brands can prepare their product and distribution records. Canonical URL: https://cosmeticaffairs.com/regulatory/fda-mandatory-cosmetic-recall-guidance-2026/ Author: [Cosmetic Affairs Editorial](https://cosmeticaffairs.com/authors/editorial/) Published: 2026-10-27T00:00:00-04:00 Editorial date: 2026-10-25 Modified: 2026-10-27T00:00:00-04:00 Collection: Regulatory Updates Topics: Regulatory, MoCRA, Manufacturing, Documentation ## Source record - Jurisdiction: United States - Issuing authority: U.S. Food and Drug Administration - Document status: Final guidance on existing statutory authority - FDA announcement: 2026-10-22 - Source checked: 2026-10-27 ### Original documents - [FDA · final guidance on mandatory cosmetics recalls](https://www.fda.gov/media/195840/download) - [FDA · announcement of final guidance](https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-final-guidance-mandatory-cosmetic-recalls) - [21 U.S.C. section 364g · mandatory recall authority](https://uscode.house.gov/us/usc/119-124/t21/s364g/) - [21 U.S.C. section 364a · adverse events](https://uscode.house.gov/us/usc/119-124/t21/s364a/) - [FDA · recall policy for cosmetics](https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/fda-recall-policy-cosmetics) ![Illustration of cosmetic containers, a record folder and distribution documents arranged on a table.](https://cosmeticaffairs.com/regulatory/fda-mandatory-cosmetic-recall-guidance-2026/article-illustration.png) AI-generated editorial illustration; not a photograph of actual products, records, or events. A serious product complaint can leave a cosmetics brand with urgent questions: which batches are involved, where did they go, and who can make a recall decision? On 22 October 2026, FDA issued final guidance explaining when the agency can require a responsible person to stop distributing and recall a cosmetic, and how that process works.[^1] The guidance explains FDA's approach to an authority Congress added through the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). It is not a new recall law. FDA guidance generally describes the agency's current thinking and is not itself binding; the statutory requirements and any applicable order still matter.[^2] ## When can FDA use this authority? FDA must determine that there is a reasonable probability both that the cosmetic is adulterated or misbranded **and** that using it or being exposed to it will cause serious adverse health consequences or death. A labeling problem or a complaint alone does not automatically establish that threshold.[^2] FDA says it considers the available evidence as a whole. Depending on the case, that can include sample analyses, inspection observations, serious adverse event data, complaints, and the vulnerability of the population using the product. A serious adverse event report does not automatically establish that the separate mandatory-recall threshold has been met.[^2] Serious adverse event reporting is a separate obligation. When the responsible person receives a report of a serious adverse event associated with use of its cosmetic product in the United States, the law generally requires submission to FDA, with a copy of the retail label, no later than **15 business days after receipt**. Assess that obligation independently of the recall decision; an investigation does not itself extend the deadline.[^5] The guidance applies to products within the statutory definition of a cosmetic. It says cosmetics also subject to drug or device requirements are not subject to this particular section, though other recall authorities may apply.[^2] ## Voluntary action comes first FDA says it expects most violative cosmetics to continue to be recalled voluntarily. If the agency makes the determination needed for its mandatory authority, it gives the responsible person an opportunity to voluntarily stop distribution and recall the product. FDA says it will give that opportunity in writing.[^2] Under MoCRA, the responsible person is the manufacturer, packer or distributor whose name appears on the product label under the applicable labeling provisions. A brand should establish who that is for each product and how to reach the people who can make decisions quickly.[^2] Voluntary recalls can also take place outside this mandatory-recall process. A company investigating a problem should not assume it must wait for an FDA order before deciding whether to act. ## From a stop-distribution order to a recall If the responsible person refuses or does not voluntarily stop distribution or recall within the time and manner FDA specifies, if any, FDA may order the person to immediately stop distribution. FDA may also require notices to relevant parties.[^2][^3] The responsible person must comply with the order and has an opportunity for an informal hearing on whether adequate evidence supports it. The law provides for that hearing no later than ten days after the order is issued. After the hearing opportunity, FDA may vacate the order, continue it for a specified period, or amend it to require a recall. A recall order can specify notifications, a timetable and updates to FDA.[^2][^3] For a mandatory recall under this authority, FDA says it will ensure a press release is published and that alerts and public notices are issued as appropriate. The notice identifies the affected cosmetic and the associated risk; distinguishing similar products that are not affected can also help consumers understand the scope.[^2] FDA generally expects a mandatory recall to end when it determines the order's requirements have been satisfied and follows its described termination process. A firm should not treat issuing a notice as the same thing as completing the recall.[^2] ## Prepare the information before it is needed A recall plan is most useful when someone can work through it under time pressure. Consider a fictional moisturiser sold through a website and two distributors. If a laboratory result raises a serious concern about one filling run, the team needs to identify the affected product and trace where it went while the safety assessment proceeds. For that product, assemble and periodically check: - **Product and batch identity:** formula and packaging versions, batch or lot codes, manufacture and release records, and retained sample references. Verify that the code on the product can be connected to the records. - **Distribution information:** quantities shipped, dates and recipients, including third-party warehouses and distributors. Agree how partners will identify and contact their own customers if needed. - **Decision and contact list:** the responsible person, manufacturer, quality and safety leads, legal support, distribution partners and FDA contacts, with substitutes for unavailable people. - **Investigation evidence:** complaints, adverse-event assessments, test results and the reasoning used to define the affected products. Keep uncertainty and pending investigations visible. - **Communication and follow-up:** a method to identify affected products clearly, notify recipients, track responses, reconcile returned or corrected stock and document its disposition. These are practical preparation steps, not a claim that the new guidance prescribes this exact file or universal retention period. FDA's recall resources recommend contingency planning, product coding and adequate distribution records to help locate products.[^4] An actual recall strategy and an FDA order may require additional actions. Test the plan with one product: ask a colleague to trace a selected lot from its batch record to its customers and identify the gaps. Then decide who owns each correction and how the team will confirm it has been completed. ## Sources [^1]: U.S. Food and Drug Administration. [FDA issues final guidance on mandatory cosmetic recalls](https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-final-guidance-mandatory-cosmetic-recalls), 22 October 2026. [^2]: U.S. Food and Drug Administration. [Questions and answers regarding mandatory cosmetics recalls: guidance for industry](https://www.fda.gov/media/195840/download), October 2026. [^3]: Office of the Law Revision Counsel. [21 U.S.C. § 364g: Mandatory recall authority](https://uscode.house.gov/us/usc/119-124/t21/s364g/). [^4]: U.S. Food and Drug Administration. [FDA recall policy for cosmetics](https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/fda-recall-policy-cosmetics). [^5]: Office of the Law Revision Counsel. [21 U.S.C. § 364a: Adverse events](https://uscode.house.gov/us/usc/119-124/t21/s364a/).